Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Paralytic syndromes in children: epidemiology and relationship to vaccination.

Zangwill KM, Yeh SH, Wong EJ, Marcy SM, Eriksen E, Huff KR, Lee M, Lewis EM, Black SB, Ward JI.

Pediatr Neurol. 2010 Mar;42(3):206-12. doi: 10.1016/j.pediatrneurol.2009.10.012.

PMID:
20159431
2.

Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population.

Batra JS, Eriksen EM, Zangwill KM, Lee M, Marcy SM, Ward JI; Vaccine Safety Datalink.

Pediatrics. 2009 Mar;123(3):951-8. doi: 10.1542/peds.2008-0231.

PMID:
19255025
3.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
4.

Incidence of bacterial meningitis in Asia using enhanced CSF testing: polymerase chain reaction, latex agglutination and culture.

Kennedy WA, Chang SJ, Purdy K, LE T, Kilgore PE, Kim JS, Anh DD, Huong PL, Dong BQ, Tan DM, Clemens JD, Ward JI.

Epidemiol Infect. 2007 Oct;135(7):1217-26. Epub 2007 Feb 5.

5.

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R; APERT Study Group.

Clin Infect Dis. 2006 Jul 15;43(2):151-7. Epub 2006 Jun 5.

PMID:
16779740
6.

Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. Influenzae type B disease burden.

Anh DD, Kilgore PE, Kennedy WA, Nyambat B, Long HT, Jodar L, Clemens JD, Ward JI.

Am J Trop Med Hyg. 2006 Mar;74(3):509-15.

PMID:
16525115
7.

Efficacy of an acellular pertussis vaccine among adolescents and adults.

Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, Greenberg DP, Keitel W, Barenkamp S, Bernstein DI, Edelman R, Edwards K; APERT Study Group.

N Engl J Med. 2005 Oct 13;353(15):1555-63.

8.

Economic considerations for pertussis booster vaccination in adolescents.

Hay JW, Ward JI.

Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S127-33. Review.

PMID:
15931140
9.

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.

Greenberg DP, Walker RE, Lee MS, Reisinger KS, Ward JI, Yogev R, Blatter MM, Yeh SH, Karron RA, Sangli C, Eubank L, Coelingh KL, Cordova JM, August MJ, Mehta HB, Chen W, Mendelman PM.

J Infect Dis. 2005 Apr 1;191(7):1116-22. Epub 2005 Feb 22.

PMID:
15747247
10.

Compliance with national immunization guidelines for children younger than 2 years, 1996-1999.

Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT; Centers for Disease Control and Prevention Vaccine Safety Datalink Project.

Pediatrics. 2005 Feb;115(2):461-7.

PMID:
15687456
11.

Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.

Cherry JD, Chang SJ, Klein D, Lee M, Barenkamp S, Bernstein D, Edelman R, Decker MD, Greenberg DP, Keitel W, Treanor J, Ward JI.

Clin Infect Dis. 2004 Dec 1;39(11):1715-8. Epub 2004 Nov 10.

PMID:
15578376
12.

Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Weiss AA, Patton AK, Millen SH, Chang SJ, Ward JI, Bernstein DI.

Infect Immun. 2004 Dec;72(12):7346-51.

13.

Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.

Kim JS, Jang YT, Kim JD, Park TH, Park JM, Kilgore PE, Kennedy WA, Park E, Nyambat B, Kim DR, Hwang PH, Kim SJ, Eun SH, Lee HS, Cho JH, Kim YS, Chang SJ, Huang HF, Clemens JD, Ward JI.

Vaccine. 2004 Sep 28;22(29-30):3952-62.

PMID:
15364444
14.

Importance of new combination vaccines.

Ward JI.

Clin Pediatr (Phila). 2004 Jul-Aug;43(6):503-4. No abstract available.

PMID:
15248002
15.

Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project.

Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, Zangwill KM, Chen RT, DeStefano F, Lewis E, Black S, Shinefield H, Ward JI.

Pediatr Infect Dis J. 2004 Jul;23(7):656-62.

PMID:
15247605
16.

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI; APERT Study.

J Infect Dis. 2004 Aug 1;190(3):535-44. Epub 2004 Jul 7.

PMID:
15243929
17.

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.

Purdy KW, Hay JW, Botteman MF, Ward JI.

Clin Infect Dis. 2004 Jul 1;39(1):20-8. Epub 2004 Jun 14.

PMID:
15206048
18.

Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.

Millen SH, Bernstein DI, Connelly B, Ward JI, Chang SJ, Weiss AA.

Infect Immun. 2004 Jan;72(1):615-20.

19.
20.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.

Zangwill KM, Greenberg DP, Chiu CY, Mendelman P, Wong VK, Chang SJ, Partridge S, Ward JI.

Vaccine. 2003 May 16;21(17-18):1894-900.

PMID:
12706674
21.

Polio extraimmunization in children younger than 2 years after changes in immunization recommendations.

Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT; CDC Vaccine Safety Datalink Project.

Pediatrics. 2003 Feb;111(2):296-301.

PMID:
12563054
23.

Childhood vaccinations and risk of asthma.

DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT; Vaccine Safety Datalink Research Group.

Pediatr Infect Dis J. 2002 Jun;21(6):498-504.

PMID:
12182372
24.

Kinetics of maternal hepatitis a antibody decay in infants: implications for vaccine use.

Lieberman JM, Chang SJ, Partridge S, Hollister JC, Kaplan KM, Jensen EH, Kuter B, Ward JI.

Pediatr Infect Dis J. 2002 Apr;21(4):347-8.

PMID:
12075769
25.

Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines.

Chang EJ, Zangwill KM, Lee H, Ward JI.

Pediatr Infect Dis J. 2002 Feb;21(2):97-102.

PMID:
11840074
26.

Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.

Wadowsky RM, Castilla EA, Laus S, Kozy A, Atchison RW, Kingsley LA, Ward JI, Greenberg DP.

J Clin Microbiol. 2002 Feb;40(2):637-40.

27.

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.

Zangwill KM, Droge J, Mendelman P, Marcy SM, Partridge S, Chiu CY, Jing J, Chang SJ, Cho I, Ward JI.

Pediatr Infect Dis J. 2001 Aug;20(8):740-6.

PMID:
11734734
28.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
29.

Strategies for development of combination vaccines.

Yeh SH, Ward JI.

Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S5-9. Review.

PMID:
11704717
30.

Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants.

Yeh SH, Ward JI, Partridge S, Marcy SM, Lee H, Jing J, Curry ES, Howe BJ.

Pediatr Infect Dis J. 2001 Oct;20(10):973-80.

PMID:
11642632
31.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

32.

Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.

Lee MS, Greenberg DP, Yeh SH, Yogev R, Reisinger KS, Ward JI, Blatter MM, Cho I, Holmes SJ, Cordova JM, August MJ, Chen W, Mehta HB, Coelingh KL, Mendelman PM.

J Infect Dis. 2001 Oct 1;184(7):909-13. Epub 2001 Aug 15.

PMID:
11509996
33.

Population-based study of rotavirus vaccination and intussusception.

Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, Chang EJ, Chen RT, Shatin D, Hill J, Lieu T, Ogren JM.

Pediatr Infect Dis J. 2001 Apr;20(4):410-6.

PMID:
11332666
34.

Does influenza vaccination prevent asthma exacerbations in children?

Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy SM; Vaccine Safety Datalink team.

J Pediatr. 2001 Mar;138(3):306-10.

PMID:
11241034
35.

Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

Greenberg DP, Wong VK, Partridge S, Chang SJ, Jing J, Howe BJ, Ward JI.

Pediatr Infect Dis J. 2000 Dec;19(12):1135-40.

PMID:
11144372
36.

The incidence of Kawasaki syndrome in West Coast health maintenance organizations.

Belay ED, Holman RC, Clarke MJ, Destefano F, Shahriari A, Davis RL, Rhodes PH, Thompson RS, Black SB, Shinefield HR, Marcy SM, Ward JI, Mullooly JP, Chen RT, Schonberger LB.

Pediatr Infect Dis J. 2000 Sep;19(9):828-32.

PMID:
11001104
37.

Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.

Miernyk KM, Parkinson AJ, Rudolph KM, Petersen KM, Bulkow LR, Greenberg DP, Ward JI, Brenneman G, Reid R, Santosham M.

Clin Infect Dis. 2000 Jul;31(1):34-41. Epub 2000 Jul 26.

PMID:
10913393
38.

Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy MS.

Arch Fam Med. 2000 Jul;9(7):617-23.

PMID:
10910309
39.

The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.

Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM.

Bull World Health Organ. 2000;78(2):186-94.

40.

Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Bohlke K, Ward JI, Marcy MS, Okoro CA.

Vaccine. 2000 Apr 28;18(21):2288-94.

PMID:
10717349
41.

Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.

Yu X, Gray B, Chang S, Ward JI, Edwards KM, Nahm MH.

J Infect Dis. 1999 Nov;180(5):1569-76.

PMID:
10515817
42.

Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team.

Parashar UD, Holman RC, Bresee JS, Clarke MJ, Rhodes PH, Davis RL, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Marcy SM, Vadheim CM, Ward JI, Chen RT, Glass RI.

Pediatr Infect Dis J. 1998 Jul;17(7):605-11.

PMID:
9686726
44.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
45.

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial.

Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI.

J Infect Dis. 1996 Oct;174(4):752-9.

PMID:
8843213
46.

Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.

Greenberg DP, Vadheim CM, Wong VK, Marcy SM, Partridge S, Greene T, Chiu CY, Margolis HS, Ward JI.

Pediatr Infect Dis J. 1996 Jul;15(7):590-6.

PMID:
8823852
47.

The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants.

Mulholland EK, Hoestermann A, Ward JI, Maine N, Ethevenaux C, Greenwood BM.

Vaccine. 1996 Jun;14(9):905-9.

PMID:
8843633
48.

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group.

Greenberg DP, Vadheim CM, Marcy SM, Partridge S, Jing J, Chiu CY, Greene T, Margolis HS, Ward JI.

Vaccine. 1996 Jun;14(8):811-6.

PMID:
8817829
49.

Invasive infections due to Haemophilus influenzae serotype f (Hif)--is Hif an emerging pathogen?

Ward JI.

Clin Infect Dis. 1996 Jun;22(6):1077-8. No abstract available.

PMID:
8783713
50.

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.

Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI.

JAMA. 1996 May 15;275(19):1499-503.

PMID:
8622225

Supplemental Content

Support Center